Netherlands Cancer Institute   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Amsterdam Netherlands (1913)

Organization Overview

First Clinical Trial
1999
NCT00003803
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Antonius Ziekenhuis | Antoni van Leeuwenhoek | Antoni van Leeuwenhoek, Amsterdam | Antoni van Leeuwenhoek Hospital | Antoni van leeuwenhoek ziekenhuis | Antoni van Leeuwenhoekziekenhuis (NKI-AVL) | AVL-NKI | Medical oncologist/researcher | National Cancer Institute-Antoni van Leuwenhoek Hospital | Nehterlands cancer institute | Netherlands Cancer Institute, Amsterdam, the Netherlands | Netherlands Cancer Institute - Antoni van Leeuwenhoek | Netherlands Comprehensive Cancer Organisation (IKNL) | The Netherlands Cancer Institute | The Netherlands Cancer Institute Amsterdam | The Netherlands Cancer Institute, Amsterdam, Netherlands | The Netherlands Cancer Institute, Amsterdam, The Netherlands | The Netherlands Cancer Institute-Antoni van Leeuwenhoek | The Netherlands Cancer Institute-Antoni van Leeuwenhoek Ziekenhuis | The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis